ION BEAM APPLICATIONS (IBAB.BR) Stock Price & Overview
EBR:IBAB • BE0003766806
Current stock price
The current stock price of IBAB.BR is 14.51 EUR. Today IBAB.BR is up by 0.9%. In the past month the price decreased by -5.15%. In the past year, price increased by 25.48%.
IBAB.BR Key Statistics
- Market Cap
- 439.363M
- P/E
- 25.46
- Fwd P/E
- 13.84
- EPS (TTM)
- 0.57
- Dividend Yield
- 1.14%
IBAB.BR Stock Performance
IBAB.BR Stock Chart
IBAB.BR Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to IBAB.BR. When comparing the yearly performance of all stocks, IBAB.BR is one of the better performing stocks in the market, outperforming 85.32% of all stocks.
IBAB.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR. IBAB.BR has a medium profitability rating, but doesn't score so well on its financial health evaluation.
IBAB.BR Earnings
IBAB.BR Forecast & Estimates
10 analysts have analysed IBAB.BR and the average price target is 15.56 EUR. This implies a price increase of 7.2% is expected in the next year compared to the current price of 14.51.
For the next year, analysts expect an EPS growth of 139.79% and a revenue growth 23.68% for IBAB.BR
IBAB.BR Groups
Sector & Classification
IBAB.BR Financial Highlights
Over the last trailing twelve months IBAB.BR reported a non-GAAP Earnings per Share(EPS) of 0.57. The EPS increased by 112.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.85% | ||
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| Debt/Equity | 0.23 |
IBAB.BR Ownership
IBAB.BR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 14.49 | 100.151B | ||
| 2M6 | MEDTRONIC PLC | 14.35 | 98.538B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.74 | 43.259B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 16.04 | 23.621B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.07 | 23.563B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 15.97 | 23.524B | ||
| BIM | BIOMERIEUX | 19.34 | 11.209B | ||
| DIA | DIASORIN SPA | 15.77 | 3.568B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.02 | 3.43B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 10.14 | 2.139B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.52 | 2.111B | ||
| DRW3 | DRAEGERWERK AG - PREF | 10.93 | 1.621B | ||
| DRW8 | DRAEGERWERK AG | 8.62 | 1.291B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About IBAB.BR
Company Profile
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 2,095 full-time employees. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
Company Info
IPO: 1998-06-13
ION BEAM APPLICATIONS
Chemin du Cyclotron 3
Louvain-la-Neuve BRABANT-WALLON BE
Employees: 1943
Phone: 3210475811
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you describe the business of ION BEAM APPLICATIONS?
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 2,095 full-time employees. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
What is the stock price of ION BEAM APPLICATIONS today?
The current stock price of IBAB.BR is 14.51 EUR. The price increased by 0.9% in the last trading session.
Does ION BEAM APPLICATIONS pay dividends?
ION BEAM APPLICATIONS (IBAB.BR) has a dividend yield of 1.14%. The yearly dividend amount is currently 0.17.
How is the ChartMill rating for ION BEAM APPLICATIONS?
IBAB.BR has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
On which exchange is IBAB.BR stock listed?
IBAB.BR stock is listed on the Euronext Brussels exchange.
What do analysts say about ION BEAM APPLICATIONS (IBAB.BR) stock?
10 analysts have analysed IBAB.BR and the average price target is 15.56 EUR. This implies a price increase of 7.2% is expected in the next year compared to the current price of 14.51.